Ali Jafarizadeh

Dr. Ali Jafarizadeh

Ophthalmology, Tabriz University of Medical Sciences, Tabrīz, Āz̄arbāyjān-e Sharqī, Iran
orcid
Ophthalmology & Digital Health researcher

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
MKMahdieh Taiyeb Khosroshahi
Mahdieh Taiyeb Khosroshahi
SMSoroush Morsali
Soroush Morsali
SGSohrab Gharakhanlou
Sohrab Gharakhanlou
AAAlireza Motamedi Alanagh
Alireza Motamedi Alanagh
SHSaeid Hassanbaghlou
Saeid Hassanbaghlou
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
Alzheimer’s disease (AD) remains a significant global health challenge, affecting millions worldwide and imposing substantial burdens on healthcare systems. Advances in artificial intelligence (AI), particularly in deep learning and machine learning, have revolutionized neuroimaging-based AD diagnosis. However, the complexity and lack of interpretability of these models limit their clinical applicability. Explainable Artificial Intelligence (XAI) addresses this challenge by providing insights into model decision-making, enhancing transparency, and fostering trust in AI-driven diagnostics. This review explores the role of XAI in AD neuroimaging, highlighting key techniques such as SHAP, LIME, Grad-CAM, and Layer-wise Relevance Propagation (LRP). We examine their applications in identifying critical biomarkers, tracking disease progression, and distinguishing AD stages using various imaging modalities, including MRI and PET. Additionally, we discuss current challenges, including dataset limitations, regulatory concerns, and standardization issues, and propose future research directions to improve XAI’s integration into clinical practice. By bridging the gap between AI and clinical interpretability, XAI holds the potential to refine AD diagnostics, personalize treatment strategies, and advance neuroimaging-based research.
3

12 April 2025 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Open access
PDF file
Navid SobhiNavid Sobhi
Navid Sobhi
YSYasin Sadeghi-Bazargani
Yasin Sadeghi-Bazargani
MMMajid Mirzaei
Majid Mirzaei
MAMirsaeed Abdollahi
Mirsaeed Abdollahi
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
Background: Diabetes mellitus (DM) increases the risk of vascular complications, and retinal vasculature imaging serves as a valuable indicator of both microvascular and macrovascular health. Moreover, artificial intelligence (AI)-enabled systems developed for high-throughput detection of diabetic retinopathy (DR) using digitized retinal images have become clinically adopted. This study reviews AI applications using retinal images for DM-related complications, highlighting advancements beyond DR screening, diagnosis, and prognosis, and addresses implementation challenges, such as ethics, data privacy, equitable access, and explainability. Methods: We conducted a thorough literature search across several databases, including PubMed, Scopus, and Web of Science, focusing on studies involving diabetes, the retina, and artificial intelligence. We reviewed the original research based on their methodology, AI algorithms, data processing techniques, and validation procedures to ensure a detailed analysis of AI applications in diabetic retinal imaging. Results: Retinal images can be used to diagnose DM complications including DR, neuropathy, nephropathy, and atherosclerotic cardiovascular disease, as well as to predict the risk of cardiovascular events. Beyond DR screening, AI integration also offers significant potential to address the challenges in the comprehensive care of patients with DM. Conclusion: With the ability to evaluate the patient’s health status in relation to DM complications as well as risk prognostication of future cardiovascular complications, AI-assisted retinal image analysis has the potential to become a central tool for modern personalized medicine in patients with DM.
3

15 February 2024 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
Hamidreza AshayeriHamidreza Ashayeri
Hamidreza Ashayeri
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
MYMilad Yousefi
Milad Yousefi
FFFereshteh Farhadi
Fereshteh Farhadi
AJAlireza Javadzadeh
Alireza Javadzadeh
3

29 March 2025 in Artificial Intelligence Review
Verified
Journal Article
Open access
PDF file
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
SMShadi Farabi Maleki
Shadi Farabi Maleki
PPParnia Pouya
Parnia Pouya
Navid SobhiNavid Sobhi
Navid Sobhi
MAMirsaeed Abdollahi
Mirsaeed Abdollahi
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
Retinopathy of prematurity (ROP) is a severe condition affecting premature infants, leading to abnormal retinal blood vessel growth, retinal detachment, and potential blindness. While semi-automated systems have been used in the past to diagnose ROP-related plus disease by quantifying retinal vessel features, traditional machine learning (ML) models face challenges like accuracy and overfitting. Recent advancements in deep learning (DL), especially convolutional neural networks (CNNs), have significantly improved ROP detection and classification. The i-ROP deep learning (i-ROP-DL) system also shows promise in detecting plus disease, offering reliable ROP diagnosis potential. This research comprehensively examines the contemporary progress and challenges associated with using retinal imaging and artificial intelligence (AI) to detect ROP, offering valuable insights that can guide further investigation in this domain. Based on 84 original studies in this field (out of 2025 studies that were comprehensively reviewed), we concluded that traditional methods for ROP diagnosis suffer from subjectivity and manual analysis, leading to inconsistent clinical decisions. AI holds great promise for improving ROP management. This review explores AI’s potential in ROP detection, classification, diagnosis, and prognosis.
3

9 October 2024 in WIREs Data Mining and Knowledge Discovery
Verified
Journal Article
Open access
MAMirsaeed Abdollahi
Mirsaeed Abdollahi
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
AGAmirhosein Ghafouri‐Asbagh
Amirhosein Ghafouri‐Asbagh
Navid SobhiNavid Sobhi
Navid Sobhi
KPKeysan Pourmoghtader
Keysan Pourmoghtader
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
Cardiovascular diseases (CVDs) are the leading cause of death globally. The use of artificial intelligence (AI) methods—in particular, deep learning (DL)—has been on the rise lately for the analysis of different CVD‐related topics. The use of fundus images and optical coherence tomography angiography (OCTA) in the diagnosis of retinal diseases has also been extensively studied. To better understand heart function and anticipate changes based on microvascular characteristics and function, researchers are currently exploring the integration of AI with noninvasive retinal scanning. There is great potential to reduce the number of cardiovascular events and the financial strain on healthcare systems by utilizing AI‐assisted early detection and prediction of cardiovascular diseases on a large scale. A comprehensive search was conducted across various databases, including PubMed, Medline, Google Scholar, Scopus, Web of Sciences, IEEE Xplore, and ACM Digital Library, using specific keywords related to cardiovascular diseases and AI. The study included 87 English‐language publications selected for relevance, and additional references were considered. This article provides an overview of the recent developments and difficulties in using AI and retinal imaging to diagnose cardiovascular diseases. It provides insights for further exploration in this field. Researchers are trying to develop precise disease prognosis patterns in response to the aging population and the growing global burden of CVD. AI and DL are revolutionizing healthcare by potentially diagnosing multiple CVDs from a single retinal image. However, swifter adoption of these technologies in healthcare systems is required.This article is categorized under: Application Areas > Health Care Technologies > Artificial Intelligence
3

13 December 2023 in Seminars in Ophthalmology
Verified
Journal Article
Closed access
SMShadi Farabi Maleki
Shadi Farabi Maleki
MYMilad Yousefi
Milad Yousefi
SASayeh Afshar
Sayeh Afshar
Siamak PedrammehrSiamak Pedrammehr
Siamak Pedrammehr
Chee Peng LimChee Peng Lim
Chee Peng Lim
Houshyar AsadiHoushyar Asadi
Houshyar Asadi
Multiple sclerosis (MS) is a complex autoimmune disease characterized by inflammatory processes, demyelination, neurodegeneration, and axonal damage within the central nervous system (CNS). Retinal imaging, particularly Optical coherence tomography (OCT), has emerged as a crucial tool for investigating MS-related retinal injury. The integration of artificial intelligence(AI) has shown promise in enhancing OCT analysis for MS. Researchers are actively utilizing AI algorithms to accurately detect and classify MS-related abnormalities, leading to improved efficiency in diagnosis, monitoring, and personalized treatment planning. The prognostic value of AI in predicting MS disease progression has garnered substantial attention. Machine learning (ML) and deep learning (DL) algorithms can analyze longitudinal OCT data to forecast the course of the disease, providing critical information for personalized treatment planning and improved patient outcomes. Early detection of high-risk patients allows for targeted interventions to mitigate disability progression effectively. As such, AI-driven approaches yielded remarkable abilities in classifying distinct MS subtypes based on retinal features, aiding in disease characterization and guiding tailored therapeutic strategies. Additionally, these algorithms have enhanced the accuracy and efficiency of OCT image segmentation, streamlined diagnostic processes, and reduced human error. This study reviews the current research studies on the integration of AI,including ML and DL algorithms, with OCT in the context of MS. It examines the advancements, challenges, potential prospects, and ethical concerns of AI-powered techniques in enhancing MS diagnosis, monitoring disease progression, revolutionizing patient care, the development of patient screening tools, and supported clinical decision-making based on OCT images.
3